Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data QUANTUM X LABS INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0.25
0.21
0.1
45.2
96.6
79.6
26.9
Cost of revenue
0.08
0
0.01
Gross profit
0.18
0.21
0.09
0.04
Research and development
-1.64
-0.35
0.26
0.23
0.11
2.37
3.26
2.89
0.83
0.07
Selling and marketing
0.18
0.26
0.01
1.35
2.48
2.81
0.31
0.1
General and administrative
-3.75
0.56
0.32
0.72
0.44
1.38
2.16
2.88
1.85
1.63
Operating expenses
-5.39
-0.56
0.76
1.21
0.55
0.4
Operating income
-5.39
-0.56
-0.58
-1
-0.45
0.54
2.73
-7.47
-0.84
-2.18
Other non-operating income
-0.75
0.31
-0
-1.28
-2.61
-11.3
Pre-tax income
-0.56
-1.1
-0.44
0.68
1.27
-8.75
-3.45
-13.4
Income tax
0.02
0.02
0
0.09
0.15
-0.07
0.13
-0.04
Income from continuing operations
-3.58
-13.4
Net income to minority interests
0.29
1.09
-1.36
-2.05
-1.53
Net income
-6.15
-1.53
-0.58
-1.12
-0.44
0.3
0.03
-7.32
-12.1
-19.3
EBITDA
-5.38
-0.54
-0.58
-1
-0.45
2.48
5.54
-4.52
-0.02
-1.34
EPS, basic
-0.32
-0.07
-2.11
-0.08
0.01
0.02
0.00
1.97
2.69
2.28
EPS, diluted
-0.32
-0.07
-2.11
-0.08
0.01
0.01
0.00
1.97
2.69
2.28
Shares, basic (weighted)
19
21.8
0.27
13.7
31.2
14.8
14.8
3.72
4.48
8.47
Shares, diluted (weighted)
19
21.8
0.27
13.7
31.2
15
15
3.72
4.48
8.47
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0
0
0.05
0.09
0.15
5.21
4.2
1.77
0.02
1.02
Short-term investments
0.02
Receivables
0.02
0.02
16.4
20.9
11.4
0.56
0.32
Other current assets
0.01
0.04
0.02
0.04
1
0.97
0.77
0.78
0.3
Total current assets
0.01
0.02
0.15
0.23
0.23
29.2
29.8
17.8
7.75
1.65
Property, plant and equipment
0.03
0.01
0.01
0.01
0.33
0.3
0.25
0.02
0.06
Lease right-of-use assets
0.57
0.49
0.4
Goodwill
12.5
17.4
12.3
1.08
6.39
Intangible assets
8.41
15.3
12.4
1.89
2.05
Total assets
0.06
0.03
0.16
0.23
0.23
51.3
63.7
43.3
22
10.8
Accounts payable
0.2
0.12
0.02
0.07
0.02
16.7
19.8
12.4
2.44
1.2
Accrued liabilities
0.16
0
0.01
6.19
5.51
3.01
0.88
0.44
Short-term debt
0.05
5.07
1.5
1.44
3.06
0.78
Total current liabilities
1.29
1.01
0.83
1.92
2.3
26.8
28.5
19.8
12.9
4.06
Long-term debt
4.27
2.88
3.06
0.5
0.59
Lease liabilities
0.49
0.39
0.3
Total liabilities
1.29
1.62
0.98
1.92
-13
32.7
33.8
24.7
14.5
5.77
Total debt
4.27
9.45
9.5
6.65
2.49
Paid-in capital
13.8
15
12.9
13
13.1
16.1
25.4
25.5
28.5
51
Retained earnings
-15
-16.6
-13.6
-14.7
-15.2
-2.37
-3.34
-10.7
-22.7
-46
Other comprehensive income
-0.02
-0.02
-0.02
Shareholders' equity
-1.24
-0.4
-0.72
-1.69
-2.08
13.7
22
14.8
5.77
4.99
Minority interests
4.81
7.88
3.81
1.74
Total equity
-1.24
-0.4
-0.72
-1.69
13.3
18.5
29.9
18.6
7.51
4.99
Total liabilities and equity
0.06
0.03
0.16
0.23
0.23
51.3
63.7
43.3
22
10.8
Shares outstanding
20
22.5
0.27
31.2
34.8
14.8
14.8
3.73
5.3
10.7
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-6.15
-1.57
-25
-1.12
-0.44
0.59
1.12
-8.69
-14.1
-20.8
Depreciation and amortization
0.01
0.02
0
0
0.01
1.94
2.81
2.95
0.81
0.85
Stock-based compensation
2.03
0.08
1.15
-0.04
0.07
0.14
0.07
0.08
Deferred income tax
0.14
0.55
-0.14
-0.04
-0.07
Change in receivables
0.03
0.02
0.5
-4.53
9.59
1.97
0.3
Change in payables
0.12
0.19
-0.1
-0.06
2.17
3.11
-7.42
-0.37
-1.23
Cash from operations
-0.86
-0.63
0.03
-0.14
-0.05
4.37
3.24
0.93
1.54
-2.77
Capital expenditures
-0.02
-0
-0.31
-0.06
-0.02
-0
Acquisitions
-11
Cash from investing
-0.04
0.01
-0
0.01
-10.8
-0.07
-0.02
-0
-0.15
Debt issued
6
1.5
Debt repaid
-0.23
-1.39
-1.81
-0.51
-3.76
Stock issued
0.05
0.53
1.94
0.05
Dividends paid
-0.92
-0.13
Cash from financing
0.78
0.61
2.04
0.17
0.1
8.28
-4.22
-3.38
-2.78
3.8
Net change in cash
-0.11
-0
0.03
0.04
0.06
1.88
-1.06
-2.46
-1.24
0.36
Free cash flow
-0.88
-0.14
4.06
3.18
0.92
1.54
Interest paid
0.08
0.56
0.92
0.68
0.41
Income taxes paid
-0.38
-0.93
-0.66
-0.12
-0.01
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $5.00 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Effective tax rate
0.1%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
-8.1%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-6.7%
Net income / average total assets.
Return on invested capital (ROIC)
-12.5%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Growth
Metric
Value
How it is calculated
EPS growth, 1y
-15.2%
EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y
176.9%
Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y
-279.5%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-13.6%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-39.0%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-51.0%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-44.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
116.7%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
89.3%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-17.4%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-22.9%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.86x
Current assets / current liabilities.
Quick ratio
0.67x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.60x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.04x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
3.1%
Total debt / total assets.
Liabilities / assets
17.3%
Total liabilities / total assets.
Net debt
-$1.5M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Book value per share
$1.37
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/B
4.18x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
39.0x
Market cap / tangible book value, when positive.
Earnings yield
-1.9%
Net income / market cap (the inverse of P/E).
Was QUANTUM X LABS INC. profitable in fiscal 2025?
No. It reported a net loss of $19.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.